Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.

Yuma WadaMitsuo ShimadaYuma WadaTetsuya IkemotoYu SaitoZhongxu ZhuXin WangAne EtxartYangsoon Park Luis Bujanda In-Ja Park Ajay Goel

Published in: JCO precision oncology (2021)

Our novel risk assessment signature for predicting response to PCRT has a potential for clinical translation as a liquid biopsy assay in patients with LARC.

Keyphrases

locally advanced
rectal cancer
risk assessment
neoadjuvant chemotherapy
human health
phase ii study
squamous cell carcinoma
radiation therapy
patients undergoing
high throughput
heavy metals
ionic liquid
fine needle aspiration
climate change
clinical trial
single cell